Forte Biosciences, Inc.FBRXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-3.13%
↑ 98% above average
Average (34q)
-132.75%
Historical baseline
Range
High:97.63%
Low:-4891.67%
Volatility
-3758.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -3.13% |
| Q2 2025 | 29.93% |
| Q1 2025 | -22.32% |
| Q4 2024 | 75.33% |
| Q3 2024 | 33.04% |
| Q2 2024 | -42.14% |
| Q1 2024 | -18.06% |
| Q4 2023 | 38.53% |
| Q3 2023 | 37.80% |
| Q2 2023 | -31.48% |
| Q1 2023 | -38.42% |
| Q4 2022 | -29.29% |
| Q3 2022 | 12.63% |
| Q2 2022 | -18.22% |
| Q1 2022 | 23.19% |
| Q4 2021 | 58.40% |
| Q3 2021 | -27.39% |
| Q2 2021 | -17.87% |
| Q1 2021 | -1.64% |
| Q4 2020 | 61.50% |
| Q3 2020 | 90.27% |
| Q2 2020 | -47.61% |
| Q1 2020 | 2.88% |
| Q4 2019 | 43.52% |
| Q3 2019 | -8.44% |
| Q2 2019 | 2.50% |
| Q1 2019 | 22.64% |
| Q4 2018 | -4891.67% |
| Q3 2018 | 97.63% |
| Q2 2018 | -25.18% |
| Q1 2018 | -17.65% |
| Q4 2017 | -10.00% |
| Q3 2017 | 10.71% |
| Q2 2017 | -36.25% |
| Q1 2017 | 0.00% |